• Strongly Investable Tchaikapharma Today (3rd September 2018)

    September 3, 2018

    Distant leader in the treatment of cardiovascular disease among all drug manufacturers present on the Bulgarian market with market share 10.57% in 2017 and 11.39% for the first half of 2018 (Source:  IQVIA/IMS Health), with deep potential for further growth following the market entry of newly developed and introduced medicaments.

    Tchaikapharma 7TH